User profiles for Raymond Wong

Raymond Chi-Wing Wong

- Verified email at cse.ust.hk - Cited by 6218

Raymond Ching Chiew Wong

- Verified email at nuhs.edu.sg - Cited by 3639

Raymond Wong

- Verified email at cityu.edu.hk - Cited by 1429

[HTML][HTML] Efficacy of mycophenolate mofetil in patients with diffuse proliferative lupus nephritis

TM Chan, FK Li, CSO Tang, RWS Wong… - … England Journal of …, 2000 - Mass Medical Soc
Background The combination of cyclophosphamide and prednisolone is effective for the
treatment of severe lupus nephritis but has serious adverse effects. Whether mycophenolate …

Plasma DNA tissue mapping by genome-wide methylation sequencing for noninvasive prenatal, cancer, and transplantation assessments

K Sun, P Jiang, KCA Chan, J Wong… - Proceedings of the …, 2015 - National Acad Sciences
Plasma consists of DNA released from multiple tissues within the body. Using genome-wide
bisulfite sequencing of plasma DNA and deconvolution of the sequencing data with …

Updated international consensus report on the investigation and management of primary immune thrombocytopenia

…, M Scully, Y Tomiyama, RS Wong… - Blood …, 2019 - ashpublications.org
Over the last decade, there have been numerous developments and changes in treatment
practices for the management of patients with immune thrombocytopenia (ITP). This article is …

Haematological manifestations in patients with severe acute respiratory syndrome: retrospective analysis

RSM Wong, A Wu, KF To, N Lee, CWK Lam, CK Wong… - Bmj, 2003 - bmj.com
Objectives To evaluate the haematological findings of patients with severe acute respiratory
syndrome (SARS). Design Analysis of the demographic, clinical, and laboratory …

Angiotensin receptor neprilysin inhibition compared with enalapril on the risk of clinical progression in surviving patients with heart failure

…, JR Teerlink, J Vanhaecke, D Vinereanu, RCC Wong - Circulation, 2015 - Am Heart Assoc
Background— Clinical trials in heart failure have focused on the improvement in symptoms
or decreases in the risk of death and other cardiovascular events. Little is known about the …

[HTML][HTML] Initial treatment of immune thrombocytopenic purpura with high-dose dexamethasone

Y Cheng, RSM Wong, YOY Soo, CH Chui… - … England Journal of …, 2003 - Mass Medical Soc
Background The role of high-dose dexamethasone in the treatment of immune
thrombocytopenic purpura in adults is controversial. We assessed the effectiveness of high-dose …

International, evidence-based consensus diagnostic criteria for HHV-8–negative/idiopathic multicentric Castleman disease

…, MJ Lechowicz, RSM Wong… - Blood, The Journal …, 2017 - ashpublications.org
Human herpesvirus-8 (HHV-8)–negative, idiopathic multicentric Castleman disease (iMCD)
is a rare and life-threatening disorder involving systemic inflammatory symptoms, polyclonal …

Can corporate governance deter management from manipulating earnings? Evidence from related-party sales transactions in China

AWY Lo, RMK Wong, M Firth - Journal of Corporate Finance, 2010 - Elsevier
This study investigates whether good governance structures help constrain management's
opportunistic behaviors (in the form of transfer pricing manipulations) in one of the world's …

[HTML][HTML] Genome-Wide Association Study in Asian Populations Identifies Variants in ETS1 and WDFY4 Associated with Systemic Lupus Erythematosus

…, RWS Wong, KW Lee, MY Mok, SN Wong… - PLoS …, 2010 - journals.plos.org
Systemic lupus erythematosus is a complex and potentially fatal autoimmune disease,
characterized by autoantibody production and multi-organ damage. By a genome-wide …

Siltuximab for multicentric Castleman's disease: a randomised, double-blind, placebo-controlled trial

F Van Rhee, RS Wong, N Munshi, JF Rossi… - The lancet …, 2014 - thelancet.com
Background Multicentric Castleman's disease is a rare lymphoproliferative disorder driven by
dysregulated production of interleukin 6. No randomised trials have been done to establish …